Key Summary
- Bristol City Council will adopt embedded harm reduction strategies to address a local overdose death rate that sits far above the national average
- Bristol-based pharmacist Ade Williams considers what this approach might mean for the community pharmacy sector.
- The plans enable “a more person-centred holistic approach with empathy and evidence embedded in public health interventions”
Bristol has been declared the UK’s first official “city of harm reduction” after local politicians voted to shift focus toward “supporting drug users rather than punishing them”.
The strategy aims to minimise the acute health and social risks associated with drug use through targeted treatment, public education, and robust support services rather than relying only on the criminal justice system.
Green Party councillor Cara Lavan, whose own partner died from a drug overdose in 2014, said that the historic decision by Bristol City Council sends a strong message to the national government that the city demands a “more compassionate, evidence-led approach” to drug policy.
Ade Williams, Bristol-based superintendent pharmacist at MJ Williams Pharmacy and lead pharmacist at Bedminster Pharmacy, told Pharmacy Business that he welcomed the expansion of the approach, which has been worked on in Bristol for some time.
“This approach is evidence-based and also enables a more person-centred holistic approach with empathy and evidence embedded in public health interventions. Bringing this into drug policy in Bristol is about saving lives and improving outcomes; we are all well aware of what does not work and the consequences that flow from this. Community pharmacy offers unique strengths in delivering evidence-based harm reduction interventions,” he said.
The announcement of Bristol’s evolving approach to drug policy may in time translate to new ways of delivering care, he suggested.
“While the specific details are yet to emerge, ensuring community pharmacy is part of both the design and delivery architecture must ultimately be the goal,” he said.
Williams said he was part of the development of a previous city-wide smoking harm reduction protocol.
He added: “It’s important for community pharmacy to be aware of not just the emergence of wider harm reduction approach, but to be active contributors to the delivery of care in an ethical, quality assured manner.
“Bringing our unique strengths can also mean owning the harm reduction approach to health delivery, especially as new neighborhood population management models emerge.”.
Lydia Plant, Chief Executive of the Bristol Drugs Project, said the declaration proudly recognised decades of progressive grassroots work across the city – ranging from needle exchange schemes to advanced drug checking services. She said it reflected Bristol's institutional commitment to “evidence and compassion over judgement”.
